Argent Trust CO Amgen Inc Transaction History

Argent Trust CO

$2.39 Billion
Q3 2024

A detailed history of Argent Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Argent Trust CO holds 26,483 shares of AMGN stock, worth $6.97 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

26,483

Previous 26,719 0.88%

Holding current value

$6.97 Million

Previous $8.35 Million 2.22%

% of portfolio

0.36%

Previous 0.37%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $73,013 - $79,621	-236 Reduced 0.88%	26,483 $8.53 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $253,291 - $307,814	964 Added 3.74%	26,719 $8.35 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $232,303 - $280,419	864 Added 3.47%	25,755 $7.32 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $200,980 - $226,729	-786 Reduced 3.06%	24,891 $7.17 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $61,877 - $76,823	283 Added 1.11%	25,677 $6.9 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $1.04 Million - $1.23 Million	4,862 Added 23.68%	25,394 $5.64 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $26,643 - $32,473	118 Added 0.58%	20,532 $4.96 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $22,444 - $28,518	-98 Reduced 0.48%	20,414 $5.36 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $459,245 - $517,944	2,046 Added 11.08%	20,512 $4.62 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $401,435 - $446,727	1,740 Added 10.4%	18,466 $4.49 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $370,127 - $409,458	1,688 Added 11.22%	16,726 $4.04 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $882,430 - $1.01 Million	-4,437 Reduced 22.78%	15,038 $3.38 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $121,842 - $142,753	574 Added 3.04%	19,475 $4.14 Million
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $734,141 - $814,477	3,143 Added 19.95%	18,901 $4.61 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $987,721 - $1.15 Million	4,451 Added 39.36%	15,758 $3.92 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $60,586 - $72,147	280 Added 2.54%	11,307 $2.6 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $110,285 - $122,646	470 Added 4.45%	11,027 $2.8 Million
Q2 2020 Aug 04, 2020	BUY	$197.81 - $242.74 $92,179 - $113,116	466 Added 4.62%	10,557 $2.49 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $80,914 - $107,314	444 Added 4.6%	10,091 $2.05 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $290,815 - $373,798	1,537 Added 18.95%	9,647 $2.33 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $26,987 - $32,336	-155 Reduced 1.88%	8,110 $1.57 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $122,191 - $143,235	-733 Reduced 8.15%	8,265 $1.52 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $652,036 - $734,987	-3,605 Reduced 28.6%	8,998 $1.71 Million
Q4 2018 Feb 06, 2019	BUY	$178.4 - $208.25 $128,448 - $149,940	720 Added 6.06%	12,603 $2.45 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $254,959 - $287,432	-1,376 Reduced 10.38%	11,883 $2.44 Million
Q2 2018 Apr 15, 2019	BUY	$166.05 - $186.51 $260,366 - $292,447	1,568 Added 13.41%	13,259 $2.45 Million
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $467,928 - $525,585	2,818 Added 31.76%	11,691 $2.16 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $240,082 - $280,566	1,417 Added 19.0%	8,873 $1.51 Million
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $47,936 - $53,559	-284 Reduced 3.67%	7,456 $1.3 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.29 Million - $1.48 Million	7,740	7,740 $1.44 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account